Sildenafil Tablet, Film Coated
Product Images NDC 13668-185

10 FDA label images from Torrent Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 13668-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)
Chemical structure of Sildenafil showing its molecular arrangement, including heterocyclic rings and functional groups consistent with the active pharmaceutical ingredient in the Sildenafil product.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A chart showing the fold change and 90% confidence intervals for AUC and Cmax of various interacting drugs compared to Sildenafil alone. Drugs listed include Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, with recommendations for dose adjustment or coadministration status noted alongside.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (AUC, Cmax, INR AUC, INR Cmax, and bleeding time) for Sildenafil when coadministered with various interacting drugs such as Acenocoumarol, Atorvastatin, Bosentan, different doses of Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. It includes recommendations for dose adjustment or coadministration advisability.*
FDA Label Image

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)
A line graph showing change from baseline in meters on the y-axis over the course of a study at weeks 4, 8, and 12 on the x-axis. The graph compares four groups: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, with error bars representing variability at each time point.*
FDA Label Image

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)
A forest plot chart illustrating placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups, including baseline walk distance, etiology, PH functional capacity class, gender, age, mean PAP, and PVRI. The chart displays sample sizes, confidence intervals, and effect estimates for each subgroup comparison.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph comparing the percentage of subjects without a clinically worsening event over time between placebo and Sildenafil groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without an event (0 to 100%). Sildenafil group consistently shows a higher percentage than placebo, indicating fewer worsening events over time.*
FDA Label Image

Pi Logo (Logo1)

FDA Label Image

Logo (Logo mg)

FDA Label Image

Image Description (Sildenafil Tablets 20mg 30s Indrad)

Image Description (Sildenafil Tablets 20mg 30s Indrad)
Label for Sildenafil Tablets, USP 20 mg film-coated tablets in a 30-tablet package. The label includes storage instructions, dosage guidance, and details for pharmacists to dispense patient information. Manufactured by Torrent Pharmaceuticals Limited, the label shows NDC 13668-185-30 and includes a barcode.*
FDA Label Image

Image Description (Sildenafil Tablets 20mg 30s Dahej)

Image Description (Sildenafil Tablets 20mg 30s Dahej)
Sildenafil Tablets USP 20 mg film-coated oral tablet label by Torrent Pharmaceuticals Limited. The package contains 30 tablets with NDC 13668-185. The label includes storage instructions, a note for pharmacists to dispense the patient information sheet, and manufacturing details for Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.